PCI Pharma Services

We conducted a survey among executives, procurement teams, supply chain managers, and product development and CMC teams to assess North American buyers' perceptions of two CDMOs acquired by PCI Pharma. This provided insights into how these acquisitions were viewed, including brand awareness, trust levels, and perceived service capabilities. Data was used to develop a brand strategy that unified PCI’s acquisitions under a cohesive identity. This directly informed branding decisions, ensuring alignment with customer expectations and trends, ultimately driving stronger client engagement and loyalty.

Animal Health CDMO Survey – Formulation and Supply Chain


Understanding Gaps and Growth Opportunities in Spray Drying


Small Molecule Lead Generation Tailored to UPM’s Service Offering


Competitive Insights for the Sterile Injectables Market

Your Shortcut to Smarter Life-Sciences Decisions
Let’s discuss how Nice Insight’s market research and pricing intelligence can deliver actionable insights for your business.